Literature DB >> 15635016

Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002).

Adam N Treitman1, Paul R Yarnold, John Warren, Gary A Noskin.   

Abstract

Historically, most clinical microbiology laboratories report that 80 to 90% of enterococci are Enterococcus faecalis, whereas E. faecium accounts for 5 to 10% of isolates. At our medical center from 1993 to 2002, we evaluated the percentages of E. faecium among all enterococcal isolates and the percentages of E. faecium isolates that were vancomycin resistant. Over this 10-year period, the percentage of enterococci that were identified as E. faecium increased from 12.7 to 22.2% (P < 0.001) and the proportion of E. faecium that was vancomycin resistant increased from 28.9 to 72.4% (P < 0.001). Both the percentage of E. faecium among the enterococci and the proportion of vancomycin-resistant E. faecium increased significantly over this 10-year period.

Entities:  

Mesh:

Year:  2005        PMID: 15635016      PMCID: PMC540171          DOI: 10.1128/JCM.43.1.462-463.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

Review 1.  SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus.

Authors:  Carlene A Muto; John A Jernigan; Belinda E Ostrowsky; Hervé M Richet; William R Jarvis; John M Boyce; Barry M Farr
Journal:  Infect Control Hosp Epidemiol       Date:  2003-05       Impact factor: 3.254

Review 2.  Emergence of Enterococcus as a significant pathogen.

Authors:  R C Moellering
Journal:  Clin Infect Dis       Date:  1992-06       Impact factor: 9.079

3.  Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: results from the SENTRY Antimicrobial Surveillance Program, 1997-1999.

Authors:  D E Low; N Keller; A Barth; R N Jones
Journal:  Clin Infect Dis       Date:  2001-05-15       Impact factor: 9.079

Review 4.  Vancomycin-resistant enterococci.

Authors:  R C Moellering
Journal:  Clin Infect Dis       Date:  1998-05       Impact factor: 9.079

5.  Linezolid resistance in a clinical isolate of Staphylococcus aureus.

Authors:  S Tsiodras; H S Gold; G Sakoulas; G M Eliopoulos; C Wennersten; L Venkataraman; R C Moellering; M J Ferraro
Journal:  Lancet       Date:  2001-07-21       Impact factor: 79.321

6.  Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci.

Authors:  J Prystowsky; F Siddiqui; J Chosay; D L Shinabarger; J Millichap; L R Peterson; G A Noskin
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

7.  Enterococcus faecium bacteremia: does vancomycin resistance make a difference?

Authors:  V Stosor; L R Peterson; M Postelnick; G A Noskin
Journal:  Arch Intern Med       Date:  1998-03-09

8.  Enterococcal bacteremia: to treat or not to treat, a reappraisal.

Authors:  C W Hoge; J Adams; B Buchanan; S D Sears
Journal:  Rev Infect Dis       Date:  1991 Jul-Aug

9.  Recommendations for preventing the spread of vancomycin resistance. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC).

Authors: 
Journal:  MMWR Recomm Rep       Date:  1995-09-22

Review 10.  Emergence of vancomycin-resistant enterococci.

Authors:  L B Rice
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

View more
  47 in total

1.  Construction of improved temperature-sensitive and mobilizable vectors and their use for constructing mutations in the adhesin-encoding acm gene of poorly transformable clinical Enterococcus faecium strains.

Authors:  Sreedhar R Nallapareddy; Kavindra V Singh; Barbara E Murray
Journal:  Appl Environ Microbiol       Date:  2006-01       Impact factor: 4.792

2.  Virulence determinants in vancomycin-resistant Enterococcus faecium vanA isolated from different sources at University Hospital of Londrina, Paraná, Brazil.

Authors:  Flávia Imanishi Ruzon; Suelen Balero de Paula; Renata Lumi Kanoshiki; Jussevania Pereira-Santos; Gilselena Kerbauy; Renata Katsuko Takayama Kobayashi; Lucy Megumi Yamauchi; Márcia Regina Eches Perugini; Sueli Fumie Yamada-Ogatta
Journal:  J Microbiol       Date:  2011-01-09       Impact factor: 3.422

3.  Characterization of the ebp(fm) pilus-encoding operon of Enterococcus faecium and its role in biofilm formation and virulence in a murine model of urinary tract infection.

Authors:  Jouko Sillanpää; Sreedhar R Nallapareddy; Kavindra V Singh; Vittal P Prakash; Timothy Fothergill; Hung Ton-That; Barbara E Murray
Journal:  Virulence       Date:  2010 Jul-Aug       Impact factor: 5.882

Review 4.  1,2,4-Triazolo[1,5-a]pyrimidines in drug design.

Authors:  Killian Oukoloff; Bobby Lucero; Karol R Francisco; Kurt R Brunden; Carlo Ballatore
Journal:  Eur J Med Chem       Date:  2019-01-14       Impact factor: 6.514

5.  Enterococcal surface protein Esp is important for biofilm formation of Enterococcus faecium E1162.

Authors:  Esther Heikens; Marc J M Bonten; Rob J L Willems
Journal:  J Bacteriol       Date:  2007-09-07       Impact factor: 3.490

6.  Pyrosequencing-based comparative genome analysis of the nosocomial pathogen Enterococcus faecium and identification of a large transferable pathogenicity island.

Authors:  Willem van Schaik; Janetta Top; David R Riley; Jos Boekhorst; Joyce E P Vrijenhoek; Claudia M E Schapendonk; Antoni P A Hendrickx; Isaäc J Nijman; Marc J M Bonten; Hervé Tettelin; Rob J L Willems
Journal:  BMC Genomics       Date:  2010-04-14       Impact factor: 3.969

7.  Increase of ceftazidime- and fluoroquinolone-resistant Klebsiella pneumoniae and imipenem-resistant Acinetobacter spp. in Korea: analysis of KONSAR study data from 2005 and 2007.

Authors:  Kyungwon Lee; Mi Ae Lee; Chae Hoon Lee; Jongwook Lee; Kyoung Ho Roh; Sunjoo Kim; Jin Ju Kim; Eunmi Koh; Dongeun Yong; Yunsop Chong
Journal:  Yonsei Med J       Date:  2010-11       Impact factor: 2.759

8.  High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004.

Authors:  Kyungwon Lee; Chang Hyun Lim; Ji Hyun Cho; Wee Gyo Lee; Young Uh; Hwi Jun Kim; Dongeun Yong; Yunsop Chong
Journal:  Yonsei Med J       Date:  2006-10-31       Impact factor: 2.759

9.  Enterococcal surface protein Esp is not essential for cell adhesion and intestinal colonization of Enterococcus faecium in mice.

Authors:  Esther Heikens; Masja Leendertse; Lucas M Wijnands; Miranda van Luit-Asbroek; Marc J M Bonten; Tom van der Poll; Rob J L Willems
Journal:  BMC Microbiol       Date:  2009-01-29       Impact factor: 3.605

10.  Intestinal colonization with Enterococcus faecium does not influence pulmonary defense against Pseudomonas aeruginosa in mice.

Authors:  Masja Leendertse; Rob J L Willems; Ida A J Giebelen; Joris J T H Roelofs; Janetta Top; Marc J M Bonten; Tom van der Poll
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.